The AntiParkinson Drugs Global Market Report 2023, provides comprehensive information on the antiparkinson drugs market across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.
Learn More On The AntiParkinson Drugs Market’s Growth:
https://www.thebusinessresearchcompany.com/report/anti-parkinson-drugs-global-market-report
As per The
Business Research Company’s AntiParkinson Drugs Global Market Report 2023, the market
size is expected to grow from $9.64 billion in 2022 to $10.23 billion in 2023
at a compound annual growth rate (CAGR) of 6.2%. The Russia-Ukraine war
disrupted the chances of global economic recovery from the COVID-19 pandemic,
at least in the short term. The war between these two countries has led to
economic sanctions on multiple countries, a surge in commodity prices, and
supply chain disruptions, causing inflation across goods and services and
affecting many markets across the globe. The market size of the global
anti-parkinson drugs is expected to grow to $12.37 billion in 2027 at a CAGR of
4.9%.
Get A Free Sample Of The Report (Includes Graphs And
Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=3462&type=smp
The antiparkinson
drugs market is segmented:
1) By Drugs
Class: Levodopa/Carbidopa, Dopamine Receptor Agonists, Monoamine Oxidase Type B
(MAO-B) Inhibitors, Catechol-O-Methyltransferase (COMT)-Inhibitors,
Anticholinergics, Other Drugs
2) By Route of
Administration: Oral, Injection, Transdermal
3) By Distribution
Channel: Hospital Pharmacies, Retailer Pharmacies, Online Pharmacies
North America was
the largest region in the antiparkinson drugs market in 2022.
The table of contents in TBRC’s antiparkinson drugs market report
includes:
1. Executive Summary
2. Anti-Parkinson Drugs Market Characteristics
3. Anti-Parkinson Drugs Market Trends And Strategies
4. Anti-Parkinson Drugs Market – Macro Economic Scenario
5. Anti-Parkinson Drugs Market Size And Growth
.
28. Anti-Parkinson Drugs Pipeline Analysis
29. Key Mergers And Acquisitions In The Anti-Parkinson Drugs Market
30. Anti-Parkinson Drugs Market Future Outlook and Potential Analysis
31. Appendix
Learn About Us:
The Business Research Company is a market intelligence
firm that pioneers in market, company, and consumer research. TBRC’s specialist
consultants are located globally and are experts in a wide range of industries
that include healthcare, manufacturing, financial services, chemicals, and
technology. The firm has offices located in the UK, the US, and India, along
with a network of proficient researchers in 28 countries. Through the report
businesses can gain a thorough understanding of the market’s size, growth rate,
major drivers and leading players.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market
Model: https://www.thebusinessresearchcompany.com/global-market-model
No comments:
Post a Comment